ccp3p41p | Knowledge4COVID-19

Property	Value
?:abstract	Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is lim-ited data on its efficacy. We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/ccp3p41p_hasAnnotation_C1538613>
?:creator	<https://research.tib.eu/covid-19/entity/Ghiasvand%2C_Fereshteh%3B_Ghadimi%2C_Maryam%3B_Sadr%2C_Sara%3B_Jafari%2C_Fatemeh%3B_Manafi%2C_Navid%3B_Ah-Madinejad%2C_Zahra%3B_Tirgar%2C_Samaneh%3B_Seyed_Alinaghi%2C_Seyed_Ahmad>
?:doi	10.2174/1871526520999201126203510
?:doi	<https://research.tib.eu/covid-19/entity/10.2174/1871526520999201126203510>
?:journal	Infectious_disorders_drug_targets
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/33243134>
?:pmid	33243134
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	Medline
?:title	COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-26

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/ccp3p41p>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/ccp3p41p>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all